"About University Retina University Retina is a full-service practice that specializes in helping patients heal eyesight-robbing diseases of the retina, vitreous, and macula. Led by a team of board-certified ophthalmologists and retina specialists, the practice has locations in Oak Forest, Bedford Park, Lemont, and Downers Grove, Illinois. With a dedication to education, technology, charity, and compassionate care, the University Retina team strives to provide patients with the highest level of retinal care in the world. The physicians diagnose and treat retinal-related conditions, including macular degeneration, diabetic retinopathy, retinal detachment repair, and other disorders of the retina, vitreous, and macula."

During the past decade, University Retina and macula Associates, PC conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Retina and macula Associates, PC" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "University Retina and macula Associates, PC" are "Diabetic Macular Edema" (4 trials), "Diabetic Retinopathy" (3 trials), "Diabetes Mellitus" (2 trials), "Geographic Atrophy" (2 trials) and "Macular Edema" (2 trials). Many other conditions were trialed in "University Retina and macula Associates, PC" in a lesser frequency.

Most popular intervention types in "University Retina and macula Associates, PC" are "Drug" (11 trials), "Other" (2 trials), "Procedure" (2 trials), "Device" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (4 trials), "Aflibercept" (3 trials), "Sham Procedure" (2 trials), "Aflibercept 2mg" (1 trials) and "LUCENTIS (ranibizumab injection)" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Retina and macula Associates, PC" are 12 trials for "All" genders.

Currently, there are NaN active trials in "University Retina and macula Associates, PC". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in University Retina and macula Associates, PC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University Retina and macula Associates, PC, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".